Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Acute × IFL protocol × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 7 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Melanoma 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Ras-mutated Metastatic Colorectal Cancer 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Breast Neoplasms 1

Interventions

venetoclax 62 Azacitidine 52 Cytarabine 33 Specimen Handling 28 Biopsy 21 fludarabine 20 Daunorubicin 18 Injections 17 Decitabine 16 Cyclophosphamide 14 fludarabine phosphate 13 Whole-Body Irradiation 12 CPX-351 12 Idarubicin 11 Melphalan 10 decitabine and cedazuridine drug combination 9 Stem Cell Transplantation 9 Busulfan 9 gilteritinib 8 Mycophenolic Acid 8 Granulocyte Colony-Stimulating Factor 8 Magnetic Resonance Spectroscopy 7 Liposomes 7 Filgrastim 7 ivosidenib 6 enasidenib 6 Gemtuzumab 6 revumenib 5 olutasidenib 5 Mesna 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡